Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Total article views   HTML views PDF downloads Totals
6,205 Dovepress* 5,017+ 442 5,459
PubMed Central* 1,188 405 1,593
Totals 6,205 847 7,052
*Since 30 July 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar